# US 2023/0202944 A1 · Methods for Rapid Formation of Chemicals Including Positron Emission Tomography Biomarkers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0202944 A1
- Document ID: US20230202944A1
- Status: Published application
- Kind: A1
- Application number: 17/998,785
- Filed: 2021-06-01
- Published: 2023-06-29
- Earliest claimed: 2020-05-29
- Assignees: Fuzionaire, Inc.
- Applicants: Fuzionaire, Inc.
- Inventors: Anton A. Toutov; Sajjad Ghobadi
- Web page: https://patentgrep.com/patent/US20230202944A1

## CPC

- C07B 59/001: {Acyclic or carbocyclic compounds}
- C07B 39/00: Halogenation
- C07B 59/002: {Heterocyclic compounds}
- C07B 59/004: {Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium}
- C07C 17/21: with simultaneous increase of the number of halogen atoms
- C07C 17/361: by reactions involving a decrease in the number of carbon atoms
- C07C 51/363: by introduction of halogen; by substitution of halogen atoms by other halogen atoms
- C07C 67/307: by introduction of halogen; by substitution of halogen atoms by other halogen atoms
- C07C 71/00: Esters of oxyacids of halogens
- C07C 253/30: by reactions not involving the formation of cyano groups
- C07D 207/09: Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D 213/61: Halogen atoms or nitro radicals
- C07D 213/68: attached in position 4
- C07D 215/12: with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D 215/18: Halogen atoms or nitro radicals
- C07D 231/56: Benzopyrazoles; Hydrogenated benzopyrazoles
- C07D 237/08: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 239/30: Halogen atoms or nitro radicals
- C07D 277/64: with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C07F 5/02: Boron compounds
- C07B 2200/05: Isotopically modified compounds, e.g. labelled
- C07F 7/123: {by reactions involving the formation of Si-halogen linkages}
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Methods for rapid, efficient, and safe fluoridation and radiolabeling of established and new biomarkers are described. More specifically, the described herein methods may be used for fluoridation of biomarkers or to facilitate isotopic exchanges, especially 19F/18F IEX, for rapid and efficient manufacturing of radiotracers, including radiotracers for positron emission tomography (PET), under clinically relevant conditions.

## Claims

### Claim 1

A method for electrospray ionization-assisted fluoridation, comprising
providing a target molecule for a fluorine isotope to be installed on and optionally dissolving the target molecule in a first solvent to obtain a target molecule solution;
providing a fluorine anion and dissolving the fluorine anion in a second solvent to obtain a fluoride solution;
mixing the target molecule solution with the fluoride solution to obtain a reaction mixture;
optionally adding one or more reagents for activation of either the fluorine anion, or the target molecule, or both to the reaction mixture;
applying an ionization potential and mode to the reaction mixture, and nebulizing the reaction mixture under the ionization potential and mode to create a plurality of microdroplets comprising the reaction mixture;
allowing the target molecule and the fluorine anion to chemically interact within the plurality of microdroplets to produce a reaction product, wherein the plurality of microdroplets continuously desolvates until collection;
collecting the plurality of microdroplets comprising the reaction product in a collection vessel;
to obtain a fluoridation product of the chemical reaction between the target molecule and the fluorine anion in clinical-quality yield and purity.

### Claim 2 (depends on 1)

The method of claim 1, wherein the fluorine anion is selected from the group consisting of 19F−, 18F−.

### Claim 3 (depends on 1)

The method of claim 1, wherein the first and second solvent are, independently selected from the solvent list consisting of: water, methanol, ethanol, other polar solvent, other biocompatible solvent known to solubilize biomolecules, dimethylformamide, acetonitrile, another anhydrous solvent, another non-nucleophilic solvent, and any combination thereof.

### Claim 4 (depends on 1)

The method of claim 1, wherein the first solvent and the second solvent are the same solvent.

### Claim 5 (depends on 1)

The method of claim 1, wherein the ionization potential is in the range from 2,000 Volts to 7,000 Volts.

### Claim 6 (depends on 1)

The method of claim 1, wherein the ionization potential is in the range from 3,500 Volts to 7,000 Volts.

### Claim 7 (depends on 1)

The method of claim 1, wherein the ionization mode is selected from the group consisting of: positive, negative.

### Claim 8 (depends on 1)

The method of claim 1, wherein additional means are provided to assist with desolvation of the plurality of microdroplets, and or to guide a flow of the plurality of microdroplets towards the collection vessel, and or to otherwise accelerate the chemical reaction within the plurality of microdroplets.

### Claim 9 (depends on 8)

The method of claim 8, wherein the additional means comprise one or more means selected from the list consisting of: utilizing a nebulizing gas heated to 25-300° C.; heating or cooling the reaction mixture at any point of the reaction; condensing, quenching, and or humidifying the plurality of microdroplets at collection; and any combination thereof.

### Claim 10 (depends on 1)

The method of claim 1, wherein the collected plurality of microdroplets are purified to isolate the reaction product prior to use.

### Claim 11 (depends on 1)

The method of claim 1, wherein the target molecule is a Fluoride Acceptor comprising a linker moiety for conjugation with a final target.

### Claim 12 (depends on 11)

The method of claim 11, wherein the Fluoride Acceptor is a prosthetic molecule selected from the group consisting of: a SiFA, a HetSiFA.

### Claim 13 (depends on 1)

The method of claim 1, wherein the target molecule comprises a Fluoride Acceptor functionality.

### Claim 14 (depends on 13)

The method of claim 13, wherein the Fluoride Acceptor functionality is a prosthetic functionality selected from the group consisting of: a SiFA functionality, a HetSiFA functionality.
